ArticleJournal of cancer survivorship : research and practice2026
Transition outcomes in a diverse cohort of higher-risk young adult survivors of childhood cancer in an established care model.
Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
purposeYoung adult survivors of childhood cancer frequently experience transition failure when transferred to adult-focused survivorship care, yet associated factors within specific care models remain poorly studied.
methodsThis retrospective cohort study included higher-risk young adult survivors transitioned from Children's Hospital Los Angeles to an affiliated adult-focused survivorship clinic from 2010 to 2018 using a protocolized pathway. Transition failure was defined as no documented adult-clinic visit within 2 years of transition launch. Late effects were defined per the Common Terminology Criteria for Adverse Events (CTCAE, v5.0).
resultsThe sample (N = 289) had mean age 22.9 years (range 17-53), was 54.0% male, and 52.2% Hispanic. Transition failure occurred in 143 (49.5%). In multivariable analyses, significantly lower odds of failure (OR, 95% CI) were observed for multiple prior pediatric survivorship visits (2 vs. 1: 0.28, 0.15-0.55; ≥ 3 vs. 1: 0.42, 0.20-0.87), higher education (college vs. high school: 0.50, 0.26-0.95), and high-dose anthracyclines (vs. none/low: 0.29, 0.11-0.77), with borderline higher odds for CTCAE-defined psychiatric disorders (2.04, 0.99-4.21). In exploratory ethnicity-stratified analysis, psychiatric disorders were associated with higher odds of failure only among Hispanic survivors (4.06, 1.37-12.01), with lower odds for age ≥ 22 years at transition (0.39, 0.16-0.95).
conclusionsAt 2 years, half of survivors experienced transition failure, which was associated with fewer prior survivorship visits and lower educational attainment; psychiatric comorbidity showed a borderline association. IMPLICATIONS FOR CANCER SURVIVORS: Even within a highly structured model, early survivorship transition failure is common, and identifiable patient subsets need additional support. More research concerning post-transition barriers is needed.
Indexed as
Identifiers
42579074What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.